✦ LIBER ✦

577 Consistent improvements in urinary urgency following repeat onabotulinumtoxinA treatments in patients with overactive bladder syndrome and urinary incontinence

✍ Scribed by Sievert, K-D.; Chapple, C.R.; Sussman, D.O.; Radomski, S.; Sand, P.K.; Guard, S.; Nardo, C.; Zhou, J.; Nitti, V.

Book ID: 122311280
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 201 KB
Volume: 13
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(14)60568-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1367 ONABOTULINUMTOXINA IN PATIENTS WITH

1367 ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE: CONSISTENT EFFECT OVER REPEAT TREATMENT

✍ Nitti, Victor W.; Sievert, Karl-Dietrich; Sussman, David; Radomski, Sidney B.; S 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 210 KB

Fesoterodine in patients with overactive

Fesoterodine in patients with overactive bladder syndrome: can the severity of baseline urgency urinary incontinence predict dosing requirement?

✍ Linda Cardozo; Vik Khullar; Joseph T. Wang; Zhonghong Guan; Peter K. Sand 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

MP80-12 SUSTAINED IMPROVEMENTS IN URINAR

MP80-12 SUSTAINED IMPROVEMENTS IN URINARY INCONTINENCE AND QUALITY OF LIFE OVER LONG-TERM TREATMENT WITH ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY

✍ Kennelly, Michael; Dmochowski, Roger; Schulte-Baukloh, Heinrich; Ethans, Karen; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 44 KB

MP38-01 LONG-TERM EFFICACY AND SAFETY OF

MP38-01 LONG-TERM EFFICACY AND SAFETY OF REPEAT ONABOTULINUMTOXINA TREATMENT IN OVERACTIVE BLADDER SYNDROME AND URINARY INCONTINENCE: THIRD INTERIM ANALYSIS, MEDIAN 2.4 YEAR FOLLOW-UP

✍ Nitti, Victor; Chapple, Christopher; Sussman, David; Radomski, Sidney; Sand, Pet 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 329 KB

Treatment satisfaction and improvement i

Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity

✍ David Sussman; Vaishali Patel; Giulio Del Popolo; Wayne Lam; Denise Globe; Peter 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

687 Treatment with fesoterodine versus t

687 Treatment with fesoterodine versus tolterodine for reducing symptom bother in elderly patients with overactive bladder including urgency urinary incontinence

✍ T. Schneider; A. Bergqvist; J. Wang; A. Wagg; C. Ebel-Bitoun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 34 KB